Celldex Therapeutics (CLDX) Q2 2023 Earnings

4MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-0.63
-0.59
-0.55
-0.51

Details

Expected EPS
-0.63
Actual EPS
-0.62
Surprise EPS
0.01
Surprise Percent
+1.59%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.62 per share for Q2 2023.

0 Comments

Share your thoughts